The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species

Cell Research

Volumn 14, Issue 1, 2004, Pages 81-85

  Gao, Fei ^a   Yi, Jing ^a   Yuan, Jing Qi ^b   Shi, Gui Ying ^a   Tang, Xue Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Arsenic trioxide; Cell cycle; Reactive oxygen species (ROS)

Indexed keywords

2,3 DIMETHOXY 1,4 NAPHTHOQUINONE; 2,3-DIMETHOXY-1,4-NAPHTHOQUINONE; 6' CARBOXYL 2',7' DICHLORODIHYDROFLUORESCEIN; 6'-CARBOXYL-2',7'-DICHLORODIHYDROFLUORESCEIN; 7 AMINODACTINOMYCIN; 7-AMINOACTINOMYCIN D; ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CATALASE; DACTINOMYCIN; DRUG DERIVATIVE; FLUORESCEIN DERIVATIVE; NAPHTHOQUINONE; ORGANOARSENIC DERIVATIVE; OXIDE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; INTERPHASE; METABOLISM; NICK END LABELING; PHYSIOLOGY; TUMOR CELL LINE;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CATALASE; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DACTINOMYCIN; FLOW CYTOMETRY; FLUORESCEINS; HUMANS; IN SITU NICK-END LABELING; INTERPHASE; NAPHTHOQUINONES; OXIDES; PROPIDIUM; REACTIVE OXYGEN SPECIES;

EID: 16544386770     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7290206     Document Type: Article

References (39)

1. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89:3354-60.
2. Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998; 339:1341-8.
3. Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001; 19(18):3852-60.
4. Wang ZY. Arsenic compounds as anticancer agents. Cancer Chemother Pharmacol 2001; 48 Suppl 1:872-76.
5. Chen Z, Chen GQ, Shen ZX, et al. Expanding the use of arsenic trioxide: leukemias and beyond. Semin Hematol 2002; 39 (2 Suppl 1):22-6.
6. th, 2000.
7. Hannun YA. Apoptosis and the Dilemma of Cancer Chemotherapy. Blood 1997; 89:1845-53.
8. Johnstone RW, Ruefli AA, Lowe SW Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108(2):153-64.
9. Chu E, Devita VT. Principle of cancer management: chemotherapy. In chief-editor Devita VT, Hellman S and Roseberg SA. Cancer principle & practice of oncology (6th edition). (USA) Philadelphia: Lippincott Williams & wilkins Press 2001; 289-307.
10. 3 is associated with the inherent cellular level of reactive oxygen species. World J Gastroenterol 2002; 8(1):36-9.
11. Yi J, Gao F, Shi GY, et al. The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide. Apoptosis 2002; 7(3):209-15.
12. Dai J, Weinberg RS, Waxman S, Jing YK Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999; 93:268-77.
13. Jing YK, Dai J, Chalmers-Redamn RE, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via hydrogen peroxide-dependent pathway. Blood 1999; 94:2102-11.
14. Papa S and Skulachev V P. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997; 174:305-19.
15. Chapple I L. Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 1997; 24:287-96.
16. Boss O, Hagen T, Lowell BB. Perspectives in diabetes. Uncoupling Protein 2 and 3 potential regulators of mitochondrial energymetabolism. Diabetes 2000; 49:143-56.
17. Carmody RJ, Cotter TG. Signalling apoptosis: a radical approach. Redox Rep 2001; 6(2):77-90.
18. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Mol Pharmacol 2001; 60(1):174-82.
19. Panaretakis T, Shabalina IG, Grander D, Shoshan MC, DePierre JW. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol Appl Pharmacol 2001; 173(1): 56-64.
20. Osawa Y, Nagaki M, Banno Y, et al. Possible involvement of reactive oxygen species in D-galactosamine-induced sensitization against tumor necrosis factor-alpha-induced hepatocyte apoptosis. J Cell Physiol 2001; 187(3):374-85.
21. Bauer G. Reactive oxygen and nitrogen species: efficient, selective, and interactive signals during intercellular induction of apoptosis. Anticancer Res 2000; 20(6B):4115-39.
22. Mary-Quillet A, Jaffrezou J, Mansa V, Bordier C, Naval J, Laurent G. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 1997; 272:21388-95.
23. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nucjear transcription factor-kappaB and activated pretein-1. J Boil Chem 1998; 273:13245-54.
24. 2+-induced apoptosis in cancer cells. Free Radic Biol Med 2002; 32(5):431-45.
25. Chandel NS, Schumacker PT, Arch RH. Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem 20016; 276(46):42728-36.
26. Isuzugawa K, Inoue M, Ogihara Y. Catalase contents in cells determine sensitivity to the apoptosis inducer gallic acid. Biol Pharm Bull 2001; 24(9):1022-6.
27. Wang TS, Kuo CF, Jan KY, Huang H. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell Physiol. 1996; 169:256-68.
28. Chen YC, Lin-Shiau SY Lin JK, Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 1998; 177:324-33.
29. Giardina C, Boulares H, Inan MS. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochim Biophys Acta 1999; 1448:425-38.
30. Ma DC, Sun YH, Chang KZ, et al. Selective induction of apoptosis of NB4 cells from G2+M phase by sodium arsenite at lower doses. Eur J Haematol 1998; 61:27-35.
31. Smith JA, Weidemann MJ. Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 1993; 162:261-8.
32. Toba K, Winton EF, Koike T, Shibata A. Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantatation using 7-amino-actinomycin D and pyronin Y. J Immunol Methods 1995; 182:193-207.
33. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
34. Shi MM, Kugelman A, Iwamoto T, Tian L, Forman HJ. Quinone-induced oxidative stress elevates glutathione and induces gamma-glutamylcysteine synthetase activity in rat lung epithelial L2 cells. J Biol Chem 1994; 269:26512-7.
35. Gorczyca W, Gong J, Ardelt B Traganos F, Darzynkiewicz Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Research 1993; 53:3186-92.
36. Donjerkovic D, Scott DW. Activation -induced cell death in B lymphocytes. Cell Research 2000; 10:179-92.
37. Allen RG and Tresini M. Oxidative Stress and Gene Regulation. Free Radic Biol 2000; 28:463-99.
38. Cai X, Shen YL, Zhu Q, et al.Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid sigaling pathway in acute promyelocytic leukemia. Leukemia 2000; 14: 262-70.
39. Desagher S, Martinou J. Mitochondria as the central control point of apoptosis. Trends in Cell Biology 2000; 10:369-77.